4.35

5.84% -0.27

Hcw Biologics Inc (HCWB)

Overview News Price History Financials Discussions Forecast

Hcw Biologics Inc stock is traded at $4.35, with a volume of 26,394. It is down -5.84% in the last 24 hours and down -55.52% over the past month. HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Previous Close:

$4.62

Open:

$4.51

24h Volume:

26,394

Relative Volume:

0.01

Market Cap:

$6.91M

Revenue:

$6.59M

Net Income/Loss:

$-18.12M

P/E Ratio:

-0.4598

EPS:

-9.4605

Net Cash Flow:

$-11.45M

1W Performance:

-12.83%

1M Performance:

-55.52%

6M Performance:

-42.00%

1Y Performance:

-82.61%

1-Day Range:

$4.30

$4.78

1-Week Range:

$4.22

$4.9789

52-Week Range:

$1.50

$44.10

Hcw Biologics Inc Stock (HCWB) Company Profile

Name

Hcw Biologics Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

954-842-2024

Address

2929 N COMMERCE PKWY, MIRAMAR

Employee

Twitter

Next Earnings Date

2026-08-17

Latest SEC Filings

HCWB's Discussions on Twitter

Compare HCWB vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HCWB Hcw Biologics Inc	4.3301	6.87M	6.59M	-18.12M	-11.45M	-9.4605
VRTX Vertex Pharmaceuticals Inc	525.12	134.02B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	673.11	68.59B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	924.88	58.44B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	319.24	41.76B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	192.23	40.23B	742.00K	-1.37B	-1.07B	-7.0731

Hcw Biologics Inc Stock (HCWB) Latest News

Jul 04, 2026

MSN Money - MSN

Jul 04, 2026

Jul 01, 2026

HCW Biologics (HCWB) clears $2.8M disputes and $1.1M lien - Stock Titan

Jul 01, 2026

Jun 30, 2026

HCW Biologics Inc.: Top Mutual Funds Holders | QNCX | US40423R3030 - marketscreener.com

Jun 30, 2026

HCW Biologics Inc.: Fundamental Analysis and Financial Ratings | QNCX | US40423R3030 - marketscreener.com

Jun 30, 2026

HCW Biologics Inc.: Dividend historical data and projections - marketscreener.com

Jun 30, 2026

HCW Biologics regains Nasdaq compliance, plans stock split - Investing.com UK

Jun 30, 2026

HCW Biologics to Implement 1-for-6 Reverse Stock Split - Moomoo

Jun 30, 2026

HCW Biologics regains Nasdaq compliance, plans stock split By Investing.com - Investing.com Nigeria

Jun 30, 2026

HCW Biologics (NASDAQ: HCWB) regains bid-price compliance and sets 1-for-6 reverse split - Stock Titan

Jun 30, 2026

HCW Biologics Regains Nasdaq Bid Price Compliance and Announces 1-for-6 Reverse Stock Split - Quiver Quantitative

Jun 30, 2026

HCW Biologics clears Nasdaq bid-price rule, then splits stock 1-for-6 - Stock Titan

Jun 30, 2026

HCW BIOL: Target Price Consensus and Analysts Recommendations | HCWB | US40423R2040 - marketscreener.com

Jun 30, 2026

Jun 29, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 29, 2026

Jun 27, 2026